Werba Rubin Papier Wealth Management Acquires 266 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Werba Rubin Papier Wealth Management boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 36.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 990 shares of the healthcare conglomerate’s stock after purchasing an additional 266 shares during the quarter. Werba Rubin Papier Wealth Management’s holdings in UnitedHealth Group were worth $504,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of UNH. Norges Bank acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at about $5,802,231,000. Swedbank AB bought a new stake in shares of UnitedHealth Group in the first quarter valued at approximately $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in UnitedHealth Group by 107.8% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock valued at $1,141,113,000 after acquiring an additional 1,196,758 shares in the last quarter. Baillie Gifford & Co. grew its holdings in shares of UnitedHealth Group by 1,125.4% during the 2nd quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate’s stock worth $455,281,000 after purchasing an additional 821,050 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado raised its stake in UnitedHealth Group by 3,464.9% in the fourth quarter. Public Employees Retirement Association of Colorado now owns 825,311 shares of the healthcare conglomerate’s stock valued at $434,501,000 after purchasing an additional 802,160 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently weighed in on the stock. Royal Bank of Canada upped their price target on shares of UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. Argus raised their price objective on UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Baird R W raised shares of UnitedHealth Group to a “strong-buy” rating in a report on Thursday, May 30th. Wells Fargo & Company upped their price objective on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Finally, JPMorgan Chase & Co. boosted their target price on shares of UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research note on Thursday, May 30th. One equities research analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $614.17.

Read Our Latest Stock Report on UnitedHealth Group

UnitedHealth Group Trading Up 0.2 %

UnitedHealth Group stock traded up $1.39 during trading hours on Friday, reaching $596.88. 2,926,369 shares of the company’s stock were exchanged, compared to its average volume of 4,070,939. The firm has a market capitalization of $549.36 billion, a PE ratio of 36.48, a PEG ratio of 1.68 and a beta of 0.58. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The firm’s 50 day simple moving average is $558.98 and its 200 day simple moving average is $515.11. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $607.94.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The firm had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period in the prior year, the business earned $6.14 EPS. Research analysts predict that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.41%. The ex-dividend date of this dividend is Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.